IP6K1 and metabolic dysfunction-associated steatotic liver disease: Ip6k1 deletion has been shown to have beneficial effects on diet- and age-induced obesity, insulin resistance, NAFLD/NASH, osteoporosis, pneumonia, and thromboembolism [16,17,19,20,21,22,50,51].